comparison of the effect of Fingolimode and Betaferon (high dose) in decreasing the symptoms and relapse rates of MS patients whose treatment with Betaferon (low dose) was failed. - E.D.S.S

Trial Profile

comparison of the effect of Fingolimode and Betaferon (high dose) in decreasing the symptoms and relapse rates of MS patients whose treatment with Betaferon (low dose) was failed. - E.D.S.S

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2016

At a glance

  • Drugs Fingolimod (Primary) ; Interferon beta-1b
  • Indications Multiple sclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 22 Sep 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top